Search

Susan Hilsenbeck Phones & Addresses

  • 5042 Cheena Dr, Houston, TX 77096 (713) 729-7032
  • San Antonio, TX
  • 17516 Birchwood Dr, Boca Raton, FL 33487
  • Miami, FL

Work

Company: Baylor college of medicine 1999 Position: Professor of medicine

Education

Degree: Doctor of Philosophy (PhD) School / High School: University of Miami 1990 Specialities: Applied Statistics

Skills

Clinical Trials • Translational Research • Lifesciences • Biostatistics • Cancer • Breast Cancer • Cell Biology • Cancer Research • Science

Ranks

Certificate: PSTATĀ® Date: 2011 Organization: Amaerican Statistical Association

Industries

Research

Resumes

Resumes

Susan Hilsenbeck Photo 1

Professor At Baylor College Of Medicine

View page
Position:
Professor of Medicine at Baylor College of Medicine
Location:
Houston, Texas Area
Industry:
Research
Work:
Baylor College of Medicine since 1999
Professor of Medicine

University of Miami, Miller School of Medicine 1977 - 1990
Assoc Director Biostatistics, Cancer Center
Education:
University of Miami 1990
Doctor of Philosophy (PhD), Applied Statistics
Skills:
Clinical Trials
Translational Research
Lifesciences
Biostatistics
Cancer
Breast Cancer
Cell Biology
Cancer Research
Science
Certifications:
PSTATĀ®, Amaerican Statistical Association

Publications

Us Patents

Aib1 As A Prognostic Marker And Predictor Of Resistance To Endocrine Therapy

View page
US Patent:
20030224467, Dec 4, 2003
Filed:
Apr 17, 2003
Appl. No.:
10/418027
Inventors:
C. Osborne - Houston TX, US
Rachel Schiff - Houston TX, US
Valerie Bardou - Marseille, FR
Susan Hilsenbeck - Houston TX, US
Gary Clark - Houston TX, US
Jiemin Wong - Pearland TX, US
Gary Chamness - Houston TX, US
Torsten Hopp - Pearland TX, US
International Classification:
C12Q001/68
G01N033/574
US Classification:
435/007230, 435/006000
Abstract:
The present invention is directed to methods involving an AIB1 polypeptide. More particularly, the methods are directed to identifying an endocrine therapy-resistant patient, to providing a prognosis for disease-free survival of a cancer patient and to treating a cancer patient that is endocrine therapy-resistant.
Susan Galloway Hilsenbeck from Houston, TX, age ~72 Get Report